Find a Tender
active
Official procurement procedure
IMPACTT PROJECT- The Supply and Delivery of COVID-19 Samples
Medical equipments
pharmaceuticals and personal care products
UK
Published value
£1,100,000
Submission deadline 15 Apr 2021, 12:00 BST
Lots published2
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Medicines Discovery Catapult: "IMPACTT PROJECT- The Supply and Delivery of COVID-19 Samples". Published status: active. Published value: £1,100,000. 2 published lots. Recorded submission deadline: 15 Apr 2021, 12:00 BST. See the official notice for participation instructions.
| Contracting Authority | Medicines Discovery Catapult | Scope & Categories | Not published | Submission Window | Closed 15 Apr 2021, 12:00 BST |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | £1,100,000 |
Bidder Intelligence · Authority Profile: Medicines Discovery Catapult
Market Analytics
Derived from OCDS awards & bid statistics
Published history for Medicines Discovery Catapult. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
3.5Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 8 active published awards; 6 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityMedicines Discovery Catapult | Procedure methodNot published | Procurement categoryNot published |
Statusactive | Framework / DPSFramework | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published27 Mar 2021, 16:25 GMT | Last source update27 Mar 2021, 16:25 GMT | Recurring procurementNo |
ClassificationMedical equipments, pharmaceuticals and personal care products | ||
Delivery area UK | ||
OCIDocds-h6vhtk-02a014 | ||
What is being bought
This Invitation to Tender (ITT) has been issued by MDC for the establishment of a Framework Agreement for IMPACTT PROJECT- The Supply and Delivery of COVID-19 Samples for delivery to Oncimmune.
What changed
From the official release history
- Published value updated to £1,100,000
27 Mar 2021, 16:25 GMT - Status changed to active
27 Mar 2021, 16:25 GMT - Official notice release published
27 Mar 2021, 16:25 GMT - Submission deadline changed to 15 Apr 2021, 12:00 BST
27 Mar 2021, 16:25 GMT - Buyer information updated
27 Mar 2021, 16:25 GMT
Lots and requirements (2)
Published by the contracting authority
- Lot 1 · #1Lot 1 DiscoveryactivePublished value£550,000We are looking for appropriate tender responses for the provision of SARS-COV-2 patient samples in order to appoint suppliers onto a Framework Agreement, with the aim of providing clinical samples for immune profiling. The IMPACTT project started 01/10/2020 therefore the SARS-COV-2 samples are required as soon as possible and there is a preference for banked samples which is detailed within the call off criteria section 12 of the ITT. The first set SAR-COV-2 samples are required as soon as possible, no later than 30th June 2021 (unless otherwise agreed by MDC / Oncimmune) to ensure project delivery. Sample requirements are outlined in figure 1 Sample characteristics distribution model within this document. It is anticipated that a maximum of ten (10) suppliers for each lot will be appointed to the framework agreement; however, MDC reserves the right to appoint fewer or more than this number if it is deemed to be in MDC’s best interest.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 2 · #2Lot 2 ValidationactivePublished value£550,000We are looking for appropriate tender responses for the provision of SARS-COV-2 patient samples in order to appoint suppliers onto a Framework Agreement, with the aim of providing clinical samples for immune profiling. The IMPACTT project started 01/10/2020 therefore the SARS-COV-2 samples are required as soon as possible and there is a preference for banked samples which is detailed within the call off criteria section 12 of the ITT. The first set SAR-COV-2 samples are required as soon as possible, no later than 30th June 2021 (unless otherwise agreed by MDC / Oncimmune) to ensure project delivery. Sample requirements are outlined in figure 1 Sample characteristics distribution model within this document. It is anticipated that a maximum of ten (10) suppliers for each lot will be appointed to the framework agreement; however, MDC reserves the right to appoint fewer or more than this number if it is deemed to be in MDC’s best interest.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
27 Mar 2021, 16:25 GMT - Submission deadline
15 Apr 2021, 12:00 BST
Commercial outcome and competition
AwardsNo award published |
ContractsNo contract published |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
Medicines Discovery Catapult
Contracting authority GB-FTS-1022Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published